RAD51 135G>C genetic polymorphism and the risk of prostate cancer
World Journal of Translational Medicine · 2026
DOI: 10.5528/wjtm.124005 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Translational Medicine, 2026. Verfasst von Sanghapriya Pal und 8 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Prostate cancer is the second most common cancer in men worldwide. The incidence of this cancer is constantly and rapidly increasing in India. The genetic variations of RAD51 and its paralog may contribute to the development of cancers such as breast, ovarian, endometrial, colorectal, head and neck cancer, and acute leukemia but there is a scarcity of literature regarding the role of RAD51 135G>C polymorphism in prostate cancer. AIM To evaluate RAD51 135G>C polymorphism in patients with prostate cancer. METHODS For this research, 50 patients of prostate cancer and fifty healthy controls were enrolled. Genotyping for RAD51 135G>C polymorphism was done by polymerase chain reaction-restriction fragment length polymorphism while estimation of serum total prostate specific antigen (PSA) was done by ELISA. The data were analyzed using appropriate statistical tools, considering P < 0.05 as significant. RESULTS A significant association of GC genotype with prostate cancer was observed. No significant association of genotype with total PSA level, Gleason’s score and stage of disease (P > 0.05) could be established. CONCLUSION There appears to be a role of RAD51 gene polymorphism in prostate cancer, and GC genotype may have an association with prostate cancer.
Zitieren
APA
Pal, S., Dahiya, K., Dhankhar, K., Atri, R., Dhankhar, R., Maheswari, S., Kumar, H., Chauhan, A., & Gaur, S. (2026). RAD51 135G>C genetic polymorphism and the risk of prostate cancer. World Journal of Translational Medicine. https://doi.org/10.5528/wjtm.124005
Vancouver
Pal S, Dahiya K, Dhankhar K, Atri R, Dhankhar R, Maheswari S, et al. RAD51 135G>C genetic polymorphism and the risk of prostate cancer. World Journal of Translational Medicine. 2026. doi:10.5528/wjtm.124005
BibTeX
@article{Pal2026,
author = {Pal, Sanghapriya and Dahiya, Kiran and Dhankhar, Kumud and Atri, Rajeev and Dhankhar, Rakesh and Maheswari, Saurabh and Kumar, Hemang and Chauhan, Aman and Gaur, Shweta},
title = {RAD51 135G>C genetic polymorphism and the risk of prostate cancer},
journal = {World Journal of Translational Medicine},
year = {2026},
doi = {10.5528/wjtm.124005}
}
EUVIMED